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US-Guided Percutaneous Thrombin Injection Of
Upper Extremity Pseudoaneurysms
H.R. Yoon, Evan J. Ryer, Robert P. Garvin, Thad
Neidrick, John B. Kendrick, James R. Elmore, David P.
Franklin. Geisinger Medical Center, Danville, Pa
Objectives: While percutaneous thrombin injection
for treatment of lower extremity pseudoaneurysms (PSA)
is well documented, little has been published regarding
this technique in the upper extremity. The purpose of
this investigation was to evaluate the safety and effective-
ness of ultrasonography-guided (US-guided) percutaneous
thrombin injection for the treatment of upper extremity
brachial and radial artery PSAs.
Methods: Retrospective single institution study from
January 2009 to December 2012. Demographics, PSA
size, thrombin dose, therapy outcome, and complications
were documented. Post treatment success was conﬁrmed
with Duplex US.
Results: Between January 2009 and December 2012,
86 upper extremity arterial duplex ultrasounds were per-
formed for a clinical suspicion of an upper extremity PSA.
18 ultrasounds (20.9%) demonstrated an iatrogenic upper
extremity PSA. Mean age was 73.5 6 10.6 years and 67%
(n ¼ 12) were female. Nine patients (50%) developed
a PSA after removal of 6 French sheath, ﬁve (28%) after
removal of a 5 French sheath, two (11%) following removal
of a 4 French sheath, one after failed PICC line insertion and
one following removal of a brachial arterial line. Fourteen
upper extremity PSAs (77.8%) in 18 patients were treated
with US-guided thrombin injection. Three of the 14
(21.4%) were radial artery PSAs and 11 (78.6%) were
brachial artery PSAs. Thirteen of the 14 (92.9%) attempts
at US-guided thrombin injection were successful with
a single injection. The mean injected thrombin dose was
2079 IU (range 300-8000). There were no thrombotic or
embolic complications at a mean follow-up of 19.4 months.
Conclusions: US-guided thrombin injection is safe
and effective for the treatment of iatrogenic brachial and
radial artery PSAs.
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Predictive Reliability of Hospital Readmission Rates in
Vascular Surgery
Andrew A. Gonzalez, Micah Girotti, Thomas W.
Wakeﬁeld, Justin B. Dimick. University of Michigan, Ann
Arbor, Mich
Objectives: To determine the extent to which histor-
ical readmissions rates accurately predict future readmis-
sions rates for vascular surgery.
Methods: Weexamined four years of nationalMedicare
claims data for patients undergoing open repair of abdominal
aortic aneurysm (n ¼ 36,830) and lower extremity arterial
bypass (n¼ 87,278).Using logistic regression, we calculated
risk-adjusted readmission rates for each hospital and then
52S Abstractsstratiﬁed hospitals into quintiles of readmission during two
periods of time. Using 2005-06 as an initial time period,
we applied Spearman’s rank correlation and weighted kappa
tests, to determine if hospitals tended to remain in the same
quintile or migrate to a different quintile by 2007-08.
Results: The Spearman’s rank correlation coefﬁcient
between 2005-06 rankings and 2007-08 rankings was 0.07
(P value <.004) and weighted kappa was 0.068 (P value
<.001) indicating a weak correlation between year groups.
There were major reclassiﬁcations between years with 11%
of the worst hospitals in 2005-06 being reclassiﬁed into the
best groupby2007-08.Ofhospitals ranked in the topquintile
in 2005-06, 88% were redistributed to a different quintile by
2007-08,with 21%of these later ranked in the lowest quintile.
Conclusions: Risk-adjusted 30-day readmission rates
for open repair of abdominal aortic aneurysms and for
lower extremity arterial bypasses have poor reliability.
Payers and policymakers should consider abandoning the
practice of using historical rates of readmission as targets
for current hospital performance.
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A Validated Intraoperative Assessment Tool for
Endovascular Skills
Cassidy Duran1, Brian Dunkin2, Daryl Schulz1, Vid
Fikfak2, Jean Bismuth1. 1The Methodist DeBakey Heart
& Vascular Center, Houston, Tex; 2The Methodist
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Objectives: There is growing interest in measuring
trainee performance in the operating room to provide an
objective means of assessing performance, which has led
to the development and validation of standardized assess-
ment tools for open and laparoscopic surgery. Our objec-
tive was to develop and validate a global assessment tool
for endovascular performance.
Methods: The global rating assessment device for
endovascular skill, (GRADES), measures 6 domains of
performance graded on a 5-point Likert scale (Table).
Vascular fellows were evaluated during endovascular
procedures by two trained observers. Internal consistency
was calculated using Cronbach a and inter-observer reli-
ability assessed by intraclass correlation (ICC). Construct
validity was evaluated by student’s t-test, correlating scores
with post graduate year (PGY) of training.
Results: A total of 28 assessments were performed on
a variety of venous and arterial endovascular procedures
(including lower extremity and visceral angioplasty and
stenting, endovascular aortic repair, and central venous
interventions). Total performance scores correlated with
trainee experience (P ¼ .0008), and internal consistency
was high (Cronbach’s a ¼ .84). Good inter-observer corre-
lation was demonstrated for the total score (r ¼ .83) and 5
of the 6 domains (Table).
Conclusions: This initial work conﬁrms the validity of
the grading tool for evaluating performance in endovascu-
lar procedures. The GRADES could serve as a valuable tool
for objectively evaluating performance in both live simu-
lated cases.
